Clinical Trial Update: A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of GW117 tablets for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• GW117 Tablets (GW117)

Snippet

Sponsor: Beijing Greatway Pharmaceutical Technology Co.,Ltd. | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: COMPLETED